Multi-omics Mechanisms of Lifestyle Intervention in Regulating Blood Glucose
Launched by SHANGHAI 6TH PEOPLE'S HOSPITAL ·
Trial Information
Current as of September 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how lifestyle changes—like diet and exercise—can help control blood sugar levels in people with diabetes. Researchers want to understand exactly how these changes affect the body at a detailed, molecular level by looking at genes, proteins, metabolism, and gut bacteria all together. The goal is to find the key biological processes that make lifestyle changes effective and to identify markers that show how well these changes are working. Ultimately, this information will help create better, personalized tools for diagnosing and managing diabetes.
The study is open to people of all genders, ranging from young adults to older adults (ages 18 to 74). Although the trial is not yet recruiting, participants can expect to take part in tests and analyses that look at their blood, genetics, and other biological samples to understand how their lifestyle affects their blood sugar. This research could lead to more tailored and effective diabetes treatments in the future.
Gender
ALL
Eligibility criteria
About Shanghai 6th People's Hospital
Shanghai 6th People's Hospital is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on a wide range of therapeutic areas, striving to enhance patient outcomes and contribute to medical knowledge. With a dedicated team of experienced researchers and clinicians, Shanghai 6th People's Hospital emphasizes rigorous scientific methodology and ethical standards, ensuring that all trials are conducted with the utmost integrity and patient safety in mind. Through collaboration with various stakeholders, the hospital aims to bridge the gap between clinical research and real-world application, ultimately improving healthcare delivery both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported